Obesidad-como-factor-de-alto-riesgo-en-cancer-de-colon-etapa-clnica-II

55. Meyerhardt JA, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with 
stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004; 22(4): 648-57. 
56. Chen J, et al. Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the 
PI3K/AKT pathway. Curr Drug Discov Technol. 2011; 8(2): 119-25. 
57. Guiu B, et al. Visceral fat área is an independent predictive biomarker of outcome after first-line 
bevacizumab-based treatment in metastatic colorectal cancer. 
 
 
 
	Portada
	Índice
	Resumen
	Texto
	Referencias Bibliografica